Skip to main
IVF
IVF logo

IVF Earnings Dates & Reports

IVF Most Recent Earnings

Report Date
Period EndingQ2 2023
Est. EPS-$403.20
Actual EPS-$1,152
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

IVF Earnings per Share (EPS) History

Signup for full access
Browse free

IVF Latest Earnings

The value each IVF share was expected to gain vs. the value each share gained.

IVF reported its most recent earnings on for Q2 2023, posting earnings per share (EPS) of -$1,152. This exceeded analysts' expectations of -$403.20 by 185.71%, marking a Miss.

For comparison, NAYA Biosciences Inc reported EPS of -$1,324.80 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

IVF Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025
Q3 2025
-$6.16
DeckReportListen
Q2 2025
-$63.60
DeckReportListen
Q1 2025
-$300.72
DeckReportListen
Q4 2024
-$216.96
DeckReportListen
View all

IVF Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the NAYA Biosciences Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

IVF Earnings FAQs

IVF last reported earnings on Aug 14, 2023 for Q2 2023, posting an EPS of -$1,152, which Miss the estimate of -$403.20 by 185.71%.

For Q2 2023, IVF reported an EPS of -$1,152, missing analysts' estimate of -$403.20 by 185.71%.

For Q2 2023, IVF Miss expectations with an actual EPS of -$1,152 vs. an estimated EPS of -$403.20.

Following the last earnings report on Aug 14, 2023, IVF's stock price moved — from — to —.

The next IVF earnings call is scheduled for Feb. 27, 2026, where executives will discuss financial results and outlook.

NAYA Biosciences Inc (IVF)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.